Jacek Legutko

Showing 1-9 of 9 articles

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys P, Gil R

October 23, 2020 | 10.4244/EIJ-D-19-00361

Coronary interventions

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys P, Gil R

September 24, 2019 | 10.4244/EIJ-D-19-00361

First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold

Kochman J, Kołtowski Ł, Tomaniak M, Jąkała J, Proniewska K, Legutko J, Roleder T, Piertrasik A, Rdzanek A, Kochman W, Brugaletta S, Opolski G, Regar E

April 6, 2018 | 10.4244/EIJ-D-17-00311

Coronary interventions

Reduced periprocedural mortality and bleeding rates of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from the ORPKI Polish National Registry

Siudak Z, Tokarek T, Dziewierz A, Wysocki T, Wiktorowicz A, Legutko J, Zmudka K, Dudek D

September 20, 2017 | 10.4244/EIJ-D-17-00078

Coronary interventions

Poland: coronary and structural heart interventions from 2010 to 2015

Legutko J, Siudak Z, Parma R, Ochała A, Dudek D

May 15, 2017 | 10.4244/EIJ-D-16-00836

Coronary interventions

IVUS in bifurcation stenting: what have we learned?

Legutko J, Yamawaki M, Costa R, Costa M

May 19, 2015 | 10.4244/EIJV11SVA12

Mesh covered stent in ST-segment elevation myocardial infarction

Dudek D, Dziewierz A, Rzeszutko L, Legutko J, Dobrowolski W, Rakowski T, Bartus S, Dragan J, Klecha A, Lansky A, Siudak Z, Zmudka K

November 15, 2010

Time-to-reperfusion therapy influences outcome of patients with myocardial infarction subjected to facilitated PCI

Dudek D, Dziewierz A, Rakowski T, El Masri N, Sorysz D, Zalewski J, Legutko J, Zmudka K, Piwowarska W, Dubiel J

November 20, 2005

Effect of early statin and selective cyclooxygenase-2 inhibitor therapy on C-reactive protein level after percutaneous coronary angioplasty in unstable angina

Dudek D, Heba G, Legutko J, Chyrchel M, Rakowski T, Kaluza G, Dubiel J

November 20, 2005

1

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

Optimising the delivery of self-expanding valves according to vascular access

November 20, 2020

Fatal Acute Mesenteric Ischemia Following Transcatheter Aortic Valve Replacement

November 25, 2020

Patient preferences and Heart Team decision

November 20, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Cardiovascular trials and COVID-19

Alexandra Lansky

November 25, 2020

This Week's JAA's: Win Ratio for Renal Denervation, Optimal strategy for NSTEMI in the very elderly, D-PUSH OCT Procedure...

November 24, 2020

Valvular disease